Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20946119rdf:typepubmed:Citationlld:pubmed
pubmed-article:20946119lifeskim:mentionsumls-concept:C0003864lld:lifeskim
pubmed-article:20946119lifeskim:mentionsumls-concept:C0026809lld:lifeskim
pubmed-article:20946119lifeskim:mentionsumls-concept:C0003241lld:lifeskim
pubmed-article:20946119lifeskim:mentionsumls-concept:C0021031lld:lifeskim
pubmed-article:20946119lifeskim:mentionsumls-concept:C0332255lld:lifeskim
pubmed-article:20946119lifeskim:mentionsumls-concept:C0086597lld:lifeskim
pubmed-article:20946119lifeskim:mentionsumls-concept:C0301625lld:lifeskim
pubmed-article:20946119pubmed:issue6lld:pubmed
pubmed-article:20946119pubmed:dateCreated2010-10-27lld:pubmed
pubmed-article:20946119pubmed:abstractTextFab fragments (Fabs) of antibodies maintain the ability to bind specific antigens, but lack the binding site for complement as well as the site for binding to receptors on effector cells, such as macrophages that play an important role in inflammation. In the present study, we investigated whether Fabs specific for ovalbumin (OVA) were specifically able to suppress anti-OVA antibody-mediated arthritis (AOA-MA) in mice.lld:pubmed
pubmed-article:20946119pubmed:languageenglld:pubmed
pubmed-article:20946119pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20946119pubmed:citationSubsetIMlld:pubmed
pubmed-article:20946119pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20946119pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20946119pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20946119pubmed:statusMEDLINElld:pubmed
pubmed-article:20946119pubmed:monthNovlld:pubmed
pubmed-article:20946119pubmed:issn1476-5381lld:pubmed
pubmed-article:20946119pubmed:authorpubmed-author:YoshinoSSlld:pubmed
pubmed-article:20946119pubmed:authorpubmed-author:KuramotoHHlld:pubmed
pubmed-article:20946119pubmed:authorpubmed-author:MizutaniNNlld:pubmed
pubmed-article:20946119pubmed:authorpubmed-author:SasaharaMMlld:pubmed
pubmed-article:20946119pubmed:authorpubmed-author:YamakiKKlld:pubmed
pubmed-article:20946119pubmed:authorpubmed-author:HutamekalinPi...lld:pubmed
pubmed-article:20946119pubmed:copyrightInfo© 2010 The Authors. British Journal of Pharmacology © 2010 The British Pharmacological Society.lld:pubmed
pubmed-article:20946119pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20946119pubmed:volume161lld:pubmed
pubmed-article:20946119pubmed:ownerNLMlld:pubmed
pubmed-article:20946119pubmed:authorsCompleteYlld:pubmed
pubmed-article:20946119pubmed:pagination1351-60lld:pubmed
pubmed-article:20946119pubmed:dateRevised2011-11-1lld:pubmed
pubmed-article:20946119pubmed:meshHeadingpubmed-meshheading:20946119...lld:pubmed
pubmed-article:20946119pubmed:meshHeadingpubmed-meshheading:20946119...lld:pubmed
pubmed-article:20946119pubmed:meshHeadingpubmed-meshheading:20946119...lld:pubmed
pubmed-article:20946119pubmed:meshHeadingpubmed-meshheading:20946119...lld:pubmed
pubmed-article:20946119pubmed:meshHeadingpubmed-meshheading:20946119...lld:pubmed
pubmed-article:20946119pubmed:meshHeadingpubmed-meshheading:20946119...lld:pubmed
pubmed-article:20946119pubmed:meshHeadingpubmed-meshheading:20946119...lld:pubmed
pubmed-article:20946119pubmed:meshHeadingpubmed-meshheading:20946119...lld:pubmed
pubmed-article:20946119pubmed:meshHeadingpubmed-meshheading:20946119...lld:pubmed
pubmed-article:20946119pubmed:year2010lld:pubmed
pubmed-article:20946119pubmed:articleTitleSuppression of antibody-mediated arthritis in mice by Fab fragments of the mediating antibodies.lld:pubmed
pubmed-article:20946119pubmed:affiliationDepartment of Pharmacology, Kobe Pharmaceutical University, Kobe, Japan. yoshino@kobepharma-u.ac.jplld:pubmed
pubmed-article:20946119pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20946119pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:20946119pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed